Futuristic non-antibiotic therapies to combat antibiotic resistance: A review

M Kumar, DK Sarma, S Shubham, M Kumawat… - Frontiers in …, 2021 - frontiersin.org
The looming problem of resistance to antibiotics in microorganisms is a global health
concern. The drug-resistant microorganisms originating from anthropogenic sources and …

[HTML][HTML] Nanotheranostics to target antibiotic-resistant bacteria: Strategies and applications

R Bhattacharjee, A Negi, B Bhattacharya, T Dey… - OpenNano, 2023 - Elsevier
Various health agencies, such as the European Medical Agency (EMA), Centers for Disease
Control and Prevention (CDC), and World Health Organization (WHO), timely cited the …

Nanomaterial-based antifungal therapies to combat fungal diseases aspergillosis, Coccidioidomycosis, Mucormycosis, and candidiasis

A León-Buitimea, JA Garza-Cervantes… - Pathogens, 2021 - mdpi.com
Over the last years, invasive infections caused by filamentous fungi have constituted a
serious threat to public health worldwide. Aspergillus, Coccidioides, Mucorales (the most …

Biological activities of bismuth compounds: an overview of the new findings and the old challenges not yet overcome

JS Rosário, FH Moreira, LHF Rosa, W Guerra… - Molecules, 2023 - mdpi.com
Bismuth-based drugs have been used primarily to treat ulcers caused by Helicobacter pylori
and other gastrointestinal ailments. Combined with antibiotics, these drugs also possess …

Emerging and future strategies in the management of recalcitrant Candida auris

N Bandara, L Samaranayake - Medical Mycology, 2022 - academic.oup.com
Candida auris is an emerging, multi drug resistant fungal pathogen that has caused
infectious outbreaks in over 45 countries since its first isolation over a decade ago, leading …

Promising Drug Candidates and New Strategies for Fighting against the Emerging Superbug Candida auris

M Billamboz, Z Fatima, S Hameed, S Jawhara - Microorganisms, 2021 - mdpi.com
Invasive fungal infections represent an expanding threat to public health. During the past
decade, a paradigm shift of candidiasis from Candida albicans to non-albicans Candida …

[HTML][HTML] Antifungal therapy of Candida biofilms: Past, present and future

OH Ajetunmobi, H Badali, JA Romo, G Ramage… - Biofilm, 2023 - Elsevier
Virtually all Candida species linked to clinical candidiasis are capable of forming highly
resistant biofilms on different types of surfaces, which poses an additional significant threat …

Liposomal formulation of a new antifungal hybrid compound provides protection against Candida auris in the ex vivo skin colonization model

A Jaromin, R Zarnowski, A Markowski… - Antimicrobial Agents …, 2024 - Am Soc Microbiol
The newly emerged pathogen, Candida auris, presents a serious threat to public health
worldwide. This multidrug-resistant yeast often colonizes and persists on the skin of patients …

Candida auris, a singular emergent pathogenic yeast: its resistance and new therapeutic alternatives

L Fernandes, R Ribeiro, M Henriques… - European Journal of …, 2022 - Springer
Nowadays, fungal infections affect millions of people across the world. Candida auris, a new
emergent yeast, is a worrisome pathogen because it associates with a high rate of incidence …

Recent advances and future perspectives in the pharmacological treatment of Candida auris infections

DR Giacobbe, L Magnasco, C Sepulcri… - Expert Review of …, 2021 - Taylor & Francis
Introduction Candida auris is responsible for hospital outbreaks worldwide. Some C. auris
isolates may show concomitant resistance to azoles, echinocandins, and polyenes, thereby …